应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
COSM COSMOS HEALTH INC
交易中 06-29 13:54:08 EDT
0.1749
+0.0027
+1.57%
最高
0.1767
最低
0.1671
成交量
159.08万
今开
0.1726
昨收
0.1722
日振幅
5.57%
总市值
1,086万
流通市值
839.43万
总股本
6,208万
成交额
27.45万
换手率
3.31%
流通股本
4,800万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cosmos Health与卡塔尔最大药房连锁所有者IMC签署分销协议,斩获首批31,000套Sky Premium Life产品订单
美股速递 · 06-27
Cosmos Health与卡塔尔最大药房连锁所有者IMC签署分销协议,斩获首批31,000套Sky Premium Life产品订单
Cosmos Health旗下C-sept Pro在希腊顶尖公私医院集团广受欢迎,年化销售额有望突破130万美元,毛利率约达72%
美股速递 · 06-25
Cosmos Health旗下C-sept Pro在希腊顶尖公私医院集团广受欢迎,年化销售额有望突破130万美元,毛利率约达72%
索尼影视:将收购COSM少数股权,首席执行官拉维·阿胡贾将加入COSM董事会。
智通财经 · 06-25
索尼影视:将收购COSM少数股权,首席执行官拉维·阿胡贾将加入COSM董事会。
索尼影业向巨幕初创企业COSM投资1亿美元。
智通财经 · 06-25
索尼影业向巨幕初创企业COSM投资1亿美元。
Cosmos Health签署协议部署人工智能呼叫中心,以优化订单处理、客户沟通与运营效率
美股速递 · 06-24
Cosmos Health签署协议部署人工智能呼叫中心,以优化订单处理、客户沟通与运营效率
Cosmos Health 合同制造订单量突破2500万件 该业务部门有望创造超1000万美元年度经常性利润
美股速递 · 06-22
Cosmos Health 合同制造订单量突破2500万件 该业务部门有望创造超1000万美元年度经常性利润
Cosmofarm 2026年第二季度营收突破1500万美元创纪录,年化收入超6000万美元;新增80余家药房,并扩展AI自动化与设施产能
美股速递 · 06-19
Cosmofarm 2026年第二季度营收突破1500万美元创纪录,年化收入超6000万美元;新增80余家药房,并扩展AI自动化与设施产能
Cosmos Health 更新美国产品线动态:推出四款18系列产品,预计年化收入超2270万美元,毛利润约1700万美元
美股速递 · 06-15
Cosmos Health 更新美国产品线动态:推出四款18系列产品,预计年化收入超2270万美元,毛利润约1700万美元
Cosmos Health获新合约制造订单,涵盖多种药品总计253,657单位
美股速递 · 06-13
Cosmos Health获新合约制造订单,涵盖多种药品总计253,657单位
Cosmos Health公布C-Scrub与C-Sept品牌在英希年化销售额超150万美元 计划进军欧盟市场 目标营收740万美元、毛利润530万美元
美股速递 · 06-12
Cosmos Health公布C-Scrub与C-Sept品牌在英希年化销售额超150万美元 计划进军欧盟市场 目标营收740万美元、毛利润530万美元
Cosmos Health收购案预计将即刻提升利润率、盈利能力及现金流
美股速递 · 06-12
Cosmos Health收购案预计将即刻提升利润率、盈利能力及现金流
Cosmos Health签署意向书收购欧洲GMP制药企业Doc Pharma S.a.,此举有望成为提升资产、盈利能力、产能及产品组合的转型关键
美股速递 · 06-12
Cosmos Health签署意向书收购欧洲GMP制药企业Doc Pharma S.a.,此举有望成为提升资产、盈利能力、产能及产品组合的转型关键
Cosmos Health:无意进行反向拆股,除非为维持纳斯达克上市地位所必需
美股速递 · 06-11
Cosmos Health:无意进行反向拆股,除非为维持纳斯达克上市地位所必需
Cosmos Health与Verisfield签署为期三年的合同制造协议,将生产390万个Vasclor Gest孕酮栓剂
美股速递 · 06-11
Cosmos Health与Verisfield签署为期三年的合同制造协议,将生产390万个Vasclor Gest孕酮栓剂
Cosmos Health 启用先进胶囊生产线,与Provident Pharmaceuticals签署为期五年的新合同制造协议,生产38.5万单位Certorun
美股速递 · 06-10
Cosmos Health 启用先进胶囊生产线,与Provident Pharmaceuticals签署为期五年的新合同制造协议,生产38.5万单位Certorun
Cosmos Health发布资产负债表更新:强调欧洲投资银行最高2,500万欧元融资谈判,以零稀释消除38%认股权证悬置;重申增长路径;指出近期股价下跌无已知业务原因
美股速递 · 06-02
Cosmos Health发布资产负债表更新:强调欧洲投资银行最高2,500万欧元融资谈判,以零稀释消除38%认股权证悬置;重申增长路径;指出近期股价下跌无已知业务原因
Cosmos Health 预计2029年股东权益将达9230万美元,每股收益0.73美元彰显价值创造
美股速递 · 05-26
Cosmos Health 预计2029年股东权益将达9230万美元,每股收益0.73美元彰显价值创造
Cosmos Health发布2026-2029年业绩指引:目标2029年实现2亿美元营收、7100万美元毛利及4400万美元调整后EBITDA——打造创新、高毛利且现金流强劲的医疗健康平台
美股速递 · 05-26
Cosmos Health发布2026-2029年业绩指引:目标2029年实现2亿美元营收、7100万美元毛利及4400万美元调整后EBITDA——打造创新、高毛利且现金流强劲的医疗健康平台
Cosmos Health签署意向书 斥资1150万美元收购药房分销网络 维持2027年15.58亿美元营收指引目标
美股速递 · 03-10
Cosmos Health签署意向书 斥资1150万美元收购药房分销网络 维持2027年15.58亿美元营收指引目标
Cosmos Health任命全球知名AI驱动药物研发与临床阶段生物技术专家Dimitrios Iliopoulos博士加入顾问委员会
美股速递 · 02-25
Cosmos Health任命全球知名AI驱动药物研发与临床阶段生物技术专家Dimitrios Iliopoulos博士加入顾问委员会
加载更多
公司概况
公司名称:
COSMOS HEALTH INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cosmos Health, Inc.于2009年7月21日在内华达州注册成立。该公司是一家多元化、垂直整合的全球医疗保健集团,作为仿制药、营养保健品、杀菌剂和医疗器械的制造商和分销商运营。同时,它还从事创新药物的研发、药物再利用以及远程医疗平台的运营。
发行价格:
--
{"stockData":{"symbol":"COSM","market":"US","secType":"STK","nameCN":"COSMOS HEALTH INC","latestPrice":0.1749,"timestamp":1782755580521,"preClose":0.1722,"halted":0,"volume":1590798,"delay":0,"changeRate":0.01567944250871085,"floatShares":47995000,"shares":62078400,"eps":-0.6172,"marketStatus":"交易中","change":0.0027,"latestTime":"06-29 13:54:08 EDT","open":0.1726,"high":0.1767,"low":0.1671,"amount":274501.75559598004,"amplitude":0.055749,"askPrice":0.1751,"askSize":100,"bidPrice":0.1725,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.6172,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782763200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1722,"preHourTrading":{"tag":"盘前","latestPrice":0.1739,"preClose":0.1722,"latestTime":"09:26 EDT","volume":257792,"amount":44902.12291072,"timestamp":1782739562238,"change":0.0017,"changeRate":0.009872,"amplitude":0.094077},"postHourTrading":{"tag":"盘后","latestPrice":0.17,"preClose":0.1722,"latestTime":"19:57 EDT","volume":676664,"amount":114349.274397,"timestamp":1782518223599,"change":-0.0022,"changeRate":-0.012776,"amplitude":0.0482},"volumeRatio":0.371234,"impliedVol":0.7309,"impliedVolPercentile":0.494},"requestUrl":"/m/hq/s/COSM","defaultTab":"news","newsList":[{"id":"1199574367","title":"Cosmos Health与卡塔尔最大药房连锁所有者IMC签署分销协议,斩获首批31,000套Sky Premium Life产品订单","url":"https://stock-news.laohu8.com/highlight/detail?id=1199574367","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199574367?lang=zh_cn&edition=full","pubTime":"2026-06-27 00:31","pubTimestamp":1782491473,"startTime":"0","endTime":"0","summary":"Cosmos Health已与卡塔尔最大药房连锁的所有者IMC签署分销协议,并成功获得首批31,000套Sky Premium Life产品的采购订单。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189602118","title":"Cosmos Health旗下C-sept Pro在希腊顶尖公私医院集团广受欢迎,年化销售额有望突破130万美元,毛利率约达72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189602118","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189602118?lang=zh_cn&edition=full","pubTime":"2026-06-25 03:37","pubTimestamp":1782329842,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. 旗下的C-sept Pro产品在希腊领先的公立与私立医院集团中获得了强劲的市场认可。基于当前销售势头,该产品的年化销售额预计将超过130万美元,并实现约72%的高毛利率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646810696","title":"索尼影视:将收购COSM少数股权,首席执行官拉维·阿胡贾将加入COSM董事会。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646810696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646810696?lang=zh_cn&edition=full","pubTime":"2026-06-25 02:01","pubTimestamp":1782324091,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4554","BK4577","BK4571","SONY","BK4588","BK4175","BK4078","LU0154236417.USD","BK4585","COSM","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646810667","title":"索尼影业向巨幕初创企业COSM投资1亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646810667","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646810667?lang=zh_cn&edition=full","pubTime":"2026-06-25 02:01","pubTimestamp":1782324068,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4078","BK4585","SONY","BK4175","COSM","LU0154236417.USD","BK4554","BK4577","BK4604","BK4571","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137142846","title":"Cosmos Health签署协议部署人工智能呼叫中心,以优化订单处理、客户沟通与运营效率","url":"https://stock-news.laohu8.com/highlight/detail?id=1137142846","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137142846?lang=zh_cn&edition=full","pubTime":"2026-06-24 03:36","pubTimestamp":1782243376,"startTime":"0","endTime":"0","summary":"Cosmos Health已签署一项协议,将部署人工智能驱动的呼叫中心系统。此举旨在优化订单接收流程、提升客户沟通效率,并增强整体运营效能。通过引入先进的人工智能技术,公司期望实现客户服务自动化与智能化,从而在提升响应速度的同时,降低运营成本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101836341","title":"Cosmos Health 合同制造订单量突破2500万件 该业务部门有望创造超1000万美元年度经常性利润","url":"https://stock-news.laohu8.com/highlight/detail?id=1101836341","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101836341?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:31","pubTimestamp":1782138679,"startTime":"0","endTime":"0","summary":"Cosmos Health 宣布其合同制造业务的订单总量已累积超过2500万件。基于此强劲的订单表现,公司预计该业务部门将有能力实现超过1000万美元的年度经常性利润。\n这一里程碑式的订单积累,凸显了公司在合同制造领域的市场地位和增长势头。超过2500万件的订单规模,为公司带来了可预见且稳定的收入流。据估算,该部门由此产生的年度经常性利润有望突破1000万美元大关,标志着公司在这一高价值业务板块取得了实质性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161121303","title":"Cosmofarm 2026年第二季度营收突破1500万美元创纪录,年化收入超6000万美元;新增80余家药房,并扩展AI自动化与设施产能","url":"https://stock-news.laohu8.com/highlight/detail?id=1161121303","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161121303?lang=zh_cn&edition=full","pubTime":"2026-06-19 03:35","pubTimestamp":1781811315,"startTime":"0","endTime":"0","summary":"Cosmofarm在2026年第二季度实现了超过1500万美元的创纪录营收,这相当于年化收入超过6000万美元的运营水平。公司业务版图显著扩张,新增了超过80家药房。与此同时,Cosmofarm持续加大在人工智能自动化领域的投入,并进一步扩展了其生产设施的能力,以支持未来的增长需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145559439","title":"Cosmos Health 更新美国产品线动态:推出四款18系列产品,预计年化收入超2270万美元,毛利润约1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145559439","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145559439?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:04","pubTimestamp":1781528679,"startTime":"0","endTime":"0","summary":"Cosmos Health 近日就其美国市场产品组合提供了最新进展。公司宣布推出四款全新的“18系列”产品。根据预测,这些新产品的年化收入有望超过2270万美元,并带来大约1700万美元的毛利润。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127918511","title":"Cosmos Health获新合约制造订单,涵盖多种药品总计253,657单位","url":"https://stock-news.laohu8.com/highlight/detail?id=1127918511","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127918511?lang=zh_cn&edition=full","pubTime":"2026-06-13 03:33","pubTimestamp":1781292796,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. 近日成功获得一系列新的合约制造订单,涉及多种药品,订单总量达到253,657单位。这一订单的获取,标志着公司在合同制造领域的业务拓展取得了新的进展,进一步巩固了其在医药制造服务市场的地位。公司凭借其专业的生产能力和质量控制体系,持续赢得客户信赖,此次订单涵盖的药品范围多样,体现了其灵活的生产线和满足不同客户需求的能力。新订单预计将对公司未来的营收和产能利用率产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103061805","title":"Cosmos Health公布C-Scrub与C-Sept品牌在英希年化销售额超150万美元 计划进军欧盟市场 目标营收740万美元、毛利润530万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103061805","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103061805?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:30","pubTimestamp":1781271018,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. 宣布,其旗下C-Scrub与C-Sept抗菌消毒品牌在英国和希腊市场已实现年化销售额突破150万美元。公司正积极规划将业务版图扩展至欧盟其他地区,并设定了雄心勃勃的财务目标:预计新市场扩张将带来740万美元的营收,同时贡献约530万美元的毛利润。\n这一战略举措标志着Cosmos Health在巩固现有市场地位的同时,正加速其国际化步伐。凭借C-Scrub与C-Sept产品在英希两地取得的销售势头,公司对进入更广阔的欧盟市场充满信心。此次扩张计划不仅旨在提升品牌影响力,更着眼于实现可观的收入与利润增长,为公司的长期发展注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1064131342.USD","IE000M9KFDE8.USD","LU2264538146.SGD","LU0787776722.HKD","SG9999002224.SGD","BK4585","LU1093756325.SGD","LU1894683348.USD","LU1988902786.USD","LU0683600562.USD","BK4206","LU1093756168.USD","BK4588","COSM","BK4175","BK4534","MMM","LU1894683264.USD","BK4512","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141045700","title":"Cosmos Health收购案预计将即刻提升利润率、盈利能力及现金流","url":"https://stock-news.laohu8.com/highlight/detail?id=1141045700","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141045700?lang=zh_cn&edition=full","pubTime":"2026-06-12 03:32","pubTimestamp":1781206338,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc宣布的收购交易,预计将对公司的利润率、盈利能力以及现金流产生立竿见影的积极贡献。此项战略举措旨在增强公司的财务表现,为股东创造即时价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157119070","title":"Cosmos Health签署意向书收购欧洲GMP制药企业Doc Pharma S.a.,此举有望成为提升资产、盈利能力、产能及产品组合的转型关键","url":"https://stock-news.laohu8.com/highlight/detail?id=1157119070","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157119070?lang=zh_cn&edition=full","pubTime":"2026-06-12 03:31","pubTimestamp":1781206277,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc.已与欧洲GMP认证制药企业Doc Pharma S.a.签署收购意向书,这标志着公司迈出关键转型步伐。此次收购预计将显著增强Cosmos Health的资产规模、盈利水平、生产能力和产品线多样性,为公司未来发展注入强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186618481","title":"Cosmos Health:无意进行反向拆股,除非为维持纳斯达克上市地位所必需","url":"https://stock-news.laohu8.com/highlight/detail?id=1186618481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186618481?lang=zh_cn&edition=full","pubTime":"2026-06-11 21:36","pubTimestamp":1781184996,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc 表示,公司目前无意执行反向股票拆分,除非此举是维持其在纳斯达克交易所上市资格的必要条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129683339","title":"Cosmos Health与Verisfield签署为期三年的合同制造协议,将生产390万个Vasclor Gest孕酮栓剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1129683339","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129683339?lang=zh_cn&edition=full","pubTime":"2026-06-11 03:33","pubTimestamp":1781120004,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. 已与Verisfield达成一项为期三年的合同制造协议,内容涉及生产总计390万个单位的Vasclor Gest孕酮栓剂。该协议标志着公司在其合同制造业务领域取得了重要进展,并有望在未来数年内为其带来稳定的生产订单和收入来源。Vasclor Gest是一种孕酮制剂,此类产品在妇产科领域具有明确的市场需求。此次合作不仅巩固了Cosmos Health作为合同制造服务提供商的地位,也展现了其生产能力与产品质量获得了合作伙伴的认可。长期协议的签订通常意味着双方对市场前景和合作稳定性抱有积极预期,这可能会对公司的未来业绩产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123382799","title":"Cosmos Health 启用先进胶囊生产线,与Provident Pharmaceuticals签署为期五年的新合同制造协议,生产38.5万单位Certorun","url":"https://stock-news.laohu8.com/highlight/detail?id=1123382799","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123382799?lang=zh_cn&edition=full","pubTime":"2026-06-10 03:30","pubTimestamp":1781033415,"startTime":"0","endTime":"0","summary":"Cosmos Health正式启动了一条先进的胶囊生产线,并与Provident Pharmaceuticals达成了一项为期五年的新合同制造协议。根据协议,Cosmos Health将为后者生产总计38.5万单位的Certorun产品。这一举措标志着公司生产能力与商业合作的重要扩展,旨在满足市场对特定健康产品的需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","COSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133663665","title":"Cosmos Health发布资产负债表更新:强调欧洲投资银行最高2,500万欧元融资谈判,以零稀释消除38%认股权证悬置;重申增长路径;指出近期股价下跌无已知业务原因","url":"https://stock-news.laohu8.com/highlight/detail?id=1133663665","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133663665?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:01","pubTimestamp":1780401710,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc(COSM)今日就其资产负债表状况发布最新动态。公司重点提及,目前正与欧洲投资银行进行融资协商,潜在资金规模最高可达2,500万欧元。此举旨在为公司的战略发展提供资金支持。\n与此同时,公司宣布已成功消除了38%的认股权证悬置问题,且整个过程未造成任何股权稀释。这一行动有效缓解了潜在的股权稀释压力,保护了现有股东的利益。\n管理层在更新中重申了公司既定的增长轨迹,对未来的业务发展前景保持信心。此外,公司特别指出,近期的股价下跌并无任何已知的业务基本面原因作为支撑。市场波动可能与更广泛的市场情绪或技术性因素相关,而非公司运营出现实质性问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114522865","title":"Cosmos Health 预计2029年股东权益将达9230万美元,每股收益0.73美元彰显价值创造","url":"https://stock-news.laohu8.com/highlight/detail?id=1114522865","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114522865?lang=zh_cn&edition=full","pubTime":"2026-05-26 21:38","pubTimestamp":1779802706,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc. 发布前瞻性预测,预计到2029年,公司股东权益总额将达到9230万美元。这一增长预期伴随着显著的每股价值创造,其每股收益(EPS)预计为0.73美元。该预测凸显了公司对未来财务增长和股东价值提升的坚定信心,描绘了一幅通过稳健运营实现资产积累与盈利增长的蓝图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163102045","title":"Cosmos Health发布2026-2029年业绩指引:目标2029年实现2亿美元营收、7100万美元毛利及4400万美元调整后EBITDA——打造创新、高毛利且现金流强劲的医疗健康平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1163102045","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163102045?lang=zh_cn&edition=full","pubTime":"2026-05-26 21:35","pubTimestamp":1779802541,"startTime":"0","endTime":"0","summary":"Cosmos Health公布了其2026年至2029年的战略业绩目标。该公司计划到2029年,实现年度营收达到2亿美元,毛利润达到7100万美元,调整后的税息折旧及摊销前利润(EBITDA)达到4400万美元。这一规划旨在构建一个创新性强、利润率高的医疗健康平台,并确保其拥有强大的现金生成能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197240665","title":"Cosmos Health签署意向书 斥资1150万美元收购药房分销网络 维持2027年15.58亿美元营收指引目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1197240665","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197240665?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:01","pubTimestamp":1773147700,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc.(股票代码:COSM)近日签署收购意向书,拟以1150万美元价格收购一家成熟药房分销网络。此项战略收购将显著增强公司在医药供应链领域的市场渗透力。\n与此同时,公司管理层确认将坚定不移地推进既定发展规划,持续朝着2027年实现15.58亿美元营收的战略目标稳步迈进。此次收购行动被视为实现这一宏伟蓝图的关键战略部署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116591935","title":"Cosmos Health任命全球知名AI驱动药物研发与临床阶段生物技术专家Dimitrios Iliopoulos博士加入顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1116591935","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116591935?lang=zh_cn&edition=full","pubTime":"2026-02-25 01:30","pubTimestamp":1771954225,"startTime":"0","endTime":"0","summary":"Cosmos Health Inc.(简称Cosmos Health)近日宣布,正式任命国际知名的AI驱动药物研发及临床阶段生物技术专家Dimitrios Iliopoulos博士加入公司顾问委员会。Iliopoulos博士在人工智能辅助药物发现和临床阶段生物技术研发领域拥有深厚造诣,其加入将显著提升Cosmos Health在创新药物开发方面的战略布局与技术实力。\n此次任命凸显了Cosmos Health致力于整合前沿科技与医疗健康的战略方向,通过引入顶尖行业专家,进一步强化公司在全球医疗创新领域的竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cosmoshealthinc.com","stockEarnings":[{"period":"1week","weight":-0.1912},{"period":"1month","weight":-0.3504},{"period":"3month","weight":-0.47},{"period":"6month","weight":-0.6652},{"period":"1year","weight":-0.6059},{"period":"ytd","weight":-0.6542}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cosmos Health, Inc.于2009年7月21日在内华达州注册成立。该公司是一家多元化、垂直整合的全球医疗保健集团,作为仿制药、营养保健品、杀菌剂和医疗器械的制造商和分销商运营。同时,它还从事创新药物的研发、药物再利用以及远程医疗平台的运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.062701},{"month":2,"riseRate":0.5,"avgChangeRate":-0.015272},{"month":3,"riseRate":0.25,"avgChangeRate":-0.105686},{"month":4,"riseRate":0.375,"avgChangeRate":-0.078796},{"month":5,"riseRate":0.777778,"avgChangeRate":0.052014},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.067349},{"month":7,"riseRate":0.5,"avgChangeRate":0.078733},{"month":8,"riseRate":0.5,"avgChangeRate":0.019433},{"month":9,"riseRate":0.5,"avgChangeRate":-0.025566},{"month":10,"riseRate":0.125,"avgChangeRate":-0.192817},{"month":11,"riseRate":0.625,"avgChangeRate":0.848544},{"month":12,"riseRate":0.125,"avgChangeRate":-0.179034}],"exchange":"NASDAQ","name":"COSMOS HEALTH INC","nameEN":"COSMOS HEALTH INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COSMOS HEALTH INC(COSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供COSMOS HEALTH INC(COSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"COSMOS HEALTH INC,COSM,COSMOS HEALTH INC股票,COSMOS HEALTH INC股票老虎,COSMOS HEALTH INC股票老虎国际,COSMOS HEALTH INC行情,COSMOS HEALTH INC股票行情,COSMOS HEALTH INC股价,COSMOS HEALTH INC股市,COSMOS HEALTH INC股票价格,COSMOS HEALTH INC股票交易,COSMOS HEALTH INC股票购买,COSMOS HEALTH INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COSMOS HEALTH INC(COSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供COSMOS HEALTH INC(COSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}